pseudomyxomas were treated with radioimmunotherapy. ## METHODS. All the patients received a tracer dose of iodine-131 ( 131 I) labeled B72.3 (Eng.) 3 Antti P. Jekunen, M
β¦ LIBER β¦
Three dimensional dose modelling of alpha and beta particle emitters for intraperitoneal radioimmunotherapy
β Scribed by George T.Y. Chen; John C. Roeske; Charles A. Pelizzari; Robert W. Atcher; Daniel J. Haraf; Jacob Rotmensch; Ralph R. Weichselbaum
- Publisher
- Elsevier Science
- Year
- 1989
- Tongue
- English
- Weight
- 122 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The effect of three dimensional activity
β
Joakim O. Laitinen; Kalevi J.Β A. Kairemo; Antti P. Jekunen; Tapani Korppi-Tommol
π
Article
π
1997
π
John Wiley and Sons
π
English
β 449 KB
π 2 views
Therapeutic efficacy and dose-limiting t
β
Thomas M. Behr; George Sgouros; Vassilios Vougioukas; Stavros Memtsoudis; Stefan
π
Article
π
1998
π
John Wiley and Sons
π
French
β 187 KB
Recent clinical results suggest that higher anti-tumor efficacy may be achieved with internalizing monoclonal antibodies (MAbs) at lower toxicity when labeled with Augerelectron, as compared to conventional β€-emitters. The aim of our study was to compare the toxicity and anti-tumor efficacy of the 1
Numerical model for the prediction of di
β
L. A. Oliveira; V. A. F. Costa; B. R. Baliga
π
Article
π
2008
π
John Wiley and Sons
π
English
β 334 KB
π 1 views
Characterization of the dosimetry at int
β
Michael G. McKenna; Peter Bloch; Martin D. Altschuler; Edward N. Hughes; W. Gill
π
Article
π
1991
π
Elsevier Science
π
English
β 139 KB